Avecho Biotechnology Limited (ASX:AVE)

Avecho Biotechnology Statistics

Total Valuation

ASX:AVE has a market cap or net worth of AUD 36.73 million. The enterprise value is 30.86 million.

Market Cap	36.73M
Enterprise Value	30.86M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:AVE has 3.67 billion shares outstanding. The number of shares has increased by 9.80% in one year.

Current Share Class	3.67B
Shares Outstanding	3.67B
Shares Change (YoY)	+9.80%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	23.50%
Owned by Institutions (%)	3.57%
Float	2.57B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.61
PB Ratio	44.52
P/TBV Ratio	44.52
P/FCF Ratio	n/a
P/OCF Ratio	30.83
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.52
EV / Sales	22.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.07.

Current Ratio	4.62
Quick Ratio	4.46
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-29.15

Financial Efficiency

Return on equity (ROE) is -143.71% and return on invested capital (ROIC) is -83.61%.

Return on Equity (ROE)	-143.71%
Return on Assets (ROA)	-33.53%
Return on Invested Capital (ROIC)	-83.61%
Return on Capital Employed (ROCE)	-61.87%
Weighted Average Cost of Capital (WACC)	10.03%
Revenue Per Employee	92,037
Profits Per Employee	-241,517
Employee Count	15
Asset Turnover	0.21
Inventory Turnover	4.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +233.33% in the last 52 weeks. The beta is 1.01, so ASX:AVE's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+233.33%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	53.57
Average Volume (20 Days)	4,027,324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:AVE had revenue of AUD 1.38 million and -3.62 million in losses. Loss per share was -0.00.

Revenue	1.38M
Gross Profit	859,631
Operating Income	-3.50M
Pretax Income	-3.62M
Net Income	-3.62M
EBITDA	-3.36M
EBIT	-3.50M
Loss Per Share	-0.00

Balance Sheet

The company has 5.93 million in cash and 57,123 in debt, with a net cash position of 5.88 million or 0.00 per share.

Cash & Cash Equivalents	5.93M
Total Debt	57,123
Net Cash	5.88M
Net Cash Per Share	0.00
Equity (Book Value)	825,160
Book Value Per Share	0.00
Working Capital	5.54M

Cash Flow

Operating Cash Flow	1.19M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 62.27%, with operating and profit margins of -253.71% and -262.41%.

Gross Margin	62.27%
Operating Margin	-253.71%
Pretax Margin	-262.41%
Profit Margin	-262.41%
EBITDA Margin	-243.67%
EBIT Margin	-253.71%
FCF Margin	n/a

Dividends & Yields

ASX:AVE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.80%
Shareholder Yield	-9.80%
Earnings Yield	-9.86%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:AVE has an Altman Z-Score of -52.35 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-52.35
Piotroski F-Score	5